SB 900 - This act modifies provisions relating to assisted reproductive technology. DEFINITION OF UNBORN CHILD (Section 1.205) This act modifies the definition of "unborn child" or "unborn children" to exclude human embryos created through assisted reproductive technology, including in vitro fertilization, prior to successful implantation in the uterus. These provisions are identical to SB 605 (2025) and HB 3244 (2026), and substantially similar to SB 1486 (2024), and similar to HB 2845 (2024). DIAGNOSIS AND TREATMENT OF INFERTILITY (Section 376.1211) This act requires certain health benefit plans providing pregnancy-related benefits to include coverage for the diagnosis and treatment of infertility, as described in the act. These provisions contain an exception for health benefit plans issued by or to religious institutions or organizations. These provisions are identical to HB 2724 (2026) and HB 3244 (2026), and substantially similar to HB 487 (2025). TAYLOR MIDDLETON

2026 Regular Session

SB 900 modifies Missouri's assisted reproductive technology regulations, potentially affecting fertility treatment access, embryo protections, and provider liability frameworks.

Second Read and Referred S Families, Seniors and Health Committee

Legislative bill overview

SB 900 modifies Missouri's legal framework governing assisted reproductive technology (ART), which includes procedures like in vitro fertilization (IVF), embryo transfer, and related fertility treatments. The bill adjusts existing statutes that regulate how these technologies are used, stored, and managed within the state. Specific provisions have not yet been detailed in available legislative records.

Why is this important

Assisted reproductive technology affects thousands of Missourians annually seeking fertility treatment, making regulatory changes directly relevant to healthcare access and family planning. ART legislation also touches on broader questions about embryo status, liability protections, and insurance coverage that can significantly impact both patients and healthcare providers. Given recent national attention to IVF access, state-level modifications to ART rules often become politically and socially significant.

Potential points of contention

Embryo legal status and protections – Changes to how embryos are classified or protected may satisfy some groups while alarming others with different moral or religious viewpoints

Liability and regulatory burden – Modifications to provider responsibilities could either increase safety standards or reduce compliance costs, depending on direction

Insurance and access equity – Alterations to coverage requirements or treatment definitions may expand or restrict who can access fertility services and at what cost